$9.920
+0.132 (+1.33%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ICCC por análisis de gráficos similares
Alphio's ICCC stock price prediction model matches the current ImmuCell Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.00 (+0.79%). The 1-week path is $9.91 (-0.11%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de ImmuCell Corp?
ImmuCell Corp is currently not a strong buy due to a recent decline in price and mixed financial performance. The stock is trading at $9.94, which is down 11.33% over the last 20 days, and the RSI is at 37.36, indicating potential oversold conditions. While the company reported a net income of $1,831,656 in Q2 2026, the gross margin has decreased to 33.92% from 43.72% in the previous year, which raises concerns about profitability. The main risk is the 38.9% decline in international sales, which could impact future growth.
ICCC cerró en $9.92 el Tuesday, tras subir +1.33%
ImmuCell Corp (ICCC) last closed at $9.92, gaining +1.33%. These facts feed the 1-day and 1-week ICCC price prediction above.
Factores de la previsión
Los factores de la previsión de ImmuCell Corp (ICCC) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ICCC, ordenadas por similitud.
Análisis de estacionalidad de ICCC
Historically the probability of a positive September return for ICCC is 52.38%. April offers the highest probability of a positive month at 92.19%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.